Joseph Thome
Stock Analyst at TD Cowen
(4.87)
# 329
Out of 4,442 analysts
398
Total ratings
56.9%
Success rate
24.6%
Average return
Main Sectors:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Rated: Buy | $42 → $50 | $48.07 | +4.01% | 19 | Jun 22, 2026 | |
| QURE uniQure | Maintained: Buy | n/a | $49.04 | - | 26 | Jun 17, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $275 → $300 | $241.97 | +23.98% | 34 | Jun 17, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Buy | n/a | $15.25 | - | 21 | Jun 14, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $275 | $230.25 | +19.44% | 28 | Jun 12, 2026 | |
| NGEN NervGen Pharma | Initiated Coverage: Buy | n/a | $2.06 | - | 1 | Jun 11, 2026 | |
| DRUG Bright Minds Biosciences | Maintained: Buy | n/a | $65.13 | - | 8 | May 20, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $660 → $675 | $544.33 | +24.01% | 28 | May 17, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | n/a | $28.64 | - | 2 | May 14, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $75 | $59.43 | +26.20% | 23 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.25 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 → $90 | $82.13 | +9.58% | 46 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.77 | - | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $54.61 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $145 | $111.07 | +30.55% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.24 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.24 | - | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $38.88 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $79.90 | - | 6 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.28 | - | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.37 | - | 6 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.18 | +110.36% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.05 | - | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.97 | n/a | 9 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.16 | n/a | 6 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $112.33 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.66 | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $118.63 | n/a | 1 | Oct 1, 2020 |
Alkermes
Jun 22, 2026
Rated: Buy
Price Target: $42 → $50
Current: $48.07
Upside: +4.01%
uniQure
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $49.04
Upside: -
Axsome Therapeutics
Jun 17, 2026
Maintained: Buy
Price Target: $275 → $300
Current: $241.97
Upside: +23.98%
Intellia Therapeutics
Jun 14, 2026
Maintained: Buy
Price Target: n/a
Current: $15.25
Upside: -
Jazz Pharmaceuticals
Jun 12, 2026
Maintained: Buy
Price Target: $275
Current: $230.25
Upside: +19.44%
NervGen Pharma
Jun 11, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $2.06
Upside: -
Bright Minds Biosciences
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $65.13
Upside: -
United Therapeutics
May 17, 2026
Maintained: Buy
Price Target: $660 → $675
Current: $544.33
Upside: +24.01%
MapLight Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $28.64
Upside: -
AnaptysBio
May 13, 2026
Maintained: Buy
Price Target: $75
Current: $59.43
Upside: +26.20%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1.25
Upside: -
May 8, 2026
Upgraded: Buy
Price Target: $75 → $90
Current: $82.13
Upside: +9.58%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $24.77
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $54.61
Upside: -
May 7, 2026
Rated: Buy
Price Target: $125 → $145
Current: $111.07
Upside: +30.55%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.24
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $3.24
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $38.88
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $79.90
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $17.28
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $16.37
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: $13
Current: $6.18
Upside: +110.36%
Nov 5, 2025
Maintained: Buy
Price Target: n/a
Current: $7.05
Upside: -
Jul 19, 2024
Rated: Hold
Price Target: n/a
Current: $21.97
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $3.16
Upside: n/a
Oct 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 24, 2023
Maintained: Hold
Price Target: $40
Current: $112.33
Upside: n/a
Oct 10, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $14.66
Upside: n/a
Oct 1, 2020
Reiterated: Buy
Price Target: n/a
Current: $118.63
Upside: n/a